Fitch: Generic Pharma Ratings Face Pressure From M&A Surge - Fitch Research

Fitch: Generic Pharma Ratings Face Pressure From M&A Surge

Fitch: Generic Pharma Ratings Face Pressure From M&A Surge - Fitch Research
Fitch: Generic Pharma Ratings Face Pressure From M&A Surge
Published Aug 13, 2015
643 words — Published Aug 13, 2015
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Fitch: Generic Pharma Ratings Face Pressure From M&A Surge 13 Aug 2015 6:55 AM (EDT) Fitch Ratings-London-13 August 2015: Healthcare reform in developed markets, increased spending in emerging markets and the prospect of big profits...

  
Report Type:

Press Release

Company(ies)
Pfizer Inc. , ALLERGAN UNLIMITED COMPANY , Teva Pharmaceuticals USA Inc.
Ticker(s)
PFE
Issuer
Teva Pharmaceuticals USA , Inc.
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch: Generic Pharma Ratings Face Pressure From M&A Surge" Aug 13, 2015. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Generic-Pharma-Ratings-Face-Pressure-From-M-A-Surge-989408_pr_frame>
  
APA:
Fitch Research. (). Fitch: Generic Pharma Ratings Face Pressure From M&A Surge Aug 13, 2015. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Generic-Pharma-Ratings-Face-Pressure-From-M-A-Surge-989408_pr_frame>
  
US$ 149.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.